Orthomyxoviridae Infections: all 95 studies

Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.

• Rechallenge With a Low Pathogenicity Avian H10N7 Influenza Virus in Healthy Human Volunteers Previously Challenged With H10N7 InfluenzaEnrolling by invitationNCT07215871Phase 1
• A Study to Evaluate Safety and Immunogenicity of One or Two Booster Vaccinations With H5N6 Influenza Vaccine in Adults Primed With H5N1 Influenza Vaccine or UnprimedCompletedNCT05422326Phase 2Results posted
• Study of SAB-176 in Healthy Adult ParticipantsCompletedNCT04850898Phase 2Results posted
• Lot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy AdultsCompletedNCT03321968Phase 3Results posted
• Exploring Safety & Clinical Benefit of Anti-Influenza Immunoglobulin Intravenous in Hospitalized Adults With Influenza ACompletedNCT03315104Phase 2Results posted
• Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles (VLPs) Influenza Vaccine in AdultsCompletedNCT03301051Phase 3Results posted
• Panblok H7 Vaccine Adjuvanted With AS03 or MF59CompletedNCT03283319Phase 2Results posted
• H7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology AnalysesCompletedNCT02921997Phase 2Results posted
• A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With InfluenzaCompletedNCT01231620Phase 3Results posted
• Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating InfluenzaCompletedNCT01052480Phase 2Results posted
• Infectivity, Replication & Immunogenicity of Live nH1N1 VaccineCompletedNCT01023776Phase 4Results posted
• Pivotal, Multicenter, Observer-Blind, Randomized Study of Influenza A (H1N1)2009 Monovalent Subunit Vaccine With and Without Adjuvant in Children Ages 6 to <36 MonthsCompletedNCT00996307Phase 2/3Results posted
• Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children, Adolescents and Adults (3 to 64 Years)CompletedNCT00973700Phase 3Results posted
• Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Non-Elderly and Elderly AdultsCompletedNCT00973349Phase 2/3Results posted
• Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children (3 to < 9 Years)CompletedNCT00972816Phase 2/3Results posted
• STIP: Statin Trial for Influenza PatientsTerminatedNCT00970606Not applicableResults posted
• Clinical Validation of the Point-of-Care MSD Influenza TestTerminatedNCT00863343Results posted
• Influenza Vaccine Revaccination in Ambulatory Elderly SubjectsCompletedNCT00775450Phase 2Results posted
• Study of Fluzone Vaccine Administered by Intradermal Route in Comparison With Standard Fluzone® in AdultsCompletedNCT00772109Phase 3Results posted
• Annual Study for Serum Collection for Immunogenicity and Safety Evaluation in Healthy Children Receiving Fluzone®CompletedNCT00755274Phase 4Results posted
• Phase IV Trial to Collect Safety Data and Sera for Immunogenicity Testing in Healthy Children Given Fluzone® VaccineCompletedNCT00561002Phase 4Results posted
• Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Infants and ChildrenCompletedNCT00391391Phase 2Results posted
• Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the ElderlyCompletedNCT00391053Phase 3Results posted
• Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Elderly SubjectsCompletedNCT00388583Phase 2Results posted
• A Study to Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol PlusCompletedNCT06385821Phase 3
• Dose, Safety, and Pathogenicity of a New Influenza H1N1 Challenge StrainCompletedNCT05572450Not applicable
• ECMO for COVID-19 vs Influenza A H1N1 Associated ARDSCompletedNCT05080933
• Comparison of COVID-19 and H1N1 Influenza PneumoniaCompletedNCT04933994
• Vitamine D3 Supplementation in Patients With Serum Values +/- 20ng/mlTerminatedNCT04810949Not applicable
• Tomographic Findings in COVID-19 and Influenza H1N1Status unknownNCT04499378
• Tomographic Findings in COVID-19 and InfluenzaStatus unknownNCT04497311
• Kinetics of the Immune Response to Inactivated Influenza Vaccine in Healthy AdultsCompletedNCT03743688
• Serum and Bronchoalveolar Inflammatory Parameters in Patients With Severe Adult Respiratory Distress SyndromeCompletedNCT03641690
• Active Surveillance for Adverse Events Following Immunization With the Butantan Trivalent Influenza Vaccine (2018)CompletedNCT03392207
• Centralized Reminder Recall - Flu RCT2CompletedNCT03294473Not applicable
• The Immune Response to Influenza Vaccinations in Elderly IndividualsCompletedNCT03266237Phase 4
• Immunogenicity, Safety, and Tolerability of a Plant-Derived Quadrivalent VLP Influenza Vaccine in Elderly AdultsCompletedNCT02831751Phase 2
• Immunogenicity of a Quadrivalent Virus-Like Particles (VLP) Influenza Vaccine in Healthy AdultsCompletedNCT02768805Phase 2
• Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal VLP Quadrivalent Influenza Vaccine in the Elderly PopulationCompletedNCT02236052Phase 2
• Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in AdultsCompletedNCT02233816Phase 2
• Safety, Tolerability and Immunogenicity of a Plant-made H7 Virus-like Particle (VLP) Influenza Vaccine in Adults.CompletedNCT02022163Phase 1
• Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent VLP Influenza Vaccine in AdultsCompletedNCT01991587Phase 1/2
• Immunogenicity, Safety, Tolerability of a Plant-made H5 Virus-like-particle (VLP) Influenza Vaccine.CompletedNCT01991561Phase 2
• Clinical Immunization Safety Assessment (CISA) Project: Pilot Study to Assess the Effect of Prophylactic Antipyretics on Immune Responses and Fever After IIVCompletedNCT01946594Phase 4
• Safety of H1N1 Influenza Vaccination in Pregnant WomenCompletedNCT01842997Phase 4
• Collaborative H1N1 Adjuvant Treatment (CHAT) Pilot TrialTerminatedNCT01798602Phase 2
• DNA-based Influenza Vaccine in the ElderlyCompletedNCT01587131Phase 1
• Post-marketing Clinical Observation of an Inactivated Influenza Split VaccineCompletedNCT01568788Not applicable
• Phase IV Clinical Trial of an Inactivated Influenza Split VaccineCompletedNCT01511744Phase 4
• Seasonal Influenza DNA Vaccine Prime With Trivalent Inactivated Vaccine (TIV) Boost Compared to TIV AloneCompletedNCT01498718Phase 1
• Validation of the Respirio Flu Test for the Rapid Identification of Influenza A/BCompletedNCT01431768Not applicable
• H1N1 Vaccine Safety in Manitoba, CanadaStatus unknownNCT01421251
• Study of Single Dose GHB16L2 Trivalent Influenza Vaccine in Healthy AdultsCompletedNCT01369862Phase 1/2
• Case-control Study of Pandemic A/H1N1 Influenza Risk Factors In LebanonCompletedNCT01298206
• Analysis of the Results From Influenza Rapid Test A Positive and H1N1 Real Time RT-PCRStatus unknownNCT01277380
• Immunogenicity and Safety Study of 4th LBVH0101 After the Primary Vaccination in LG-VHCL002 StudyCompletedNCT01251133Phase 3
• Safety and Efficacy Study of Interferon to Treat Patients Hospitalized for InfluenzaStatus unknownNCT01227798Phase 1/2
• A Study of the Pharmacology of Tamiflu in PregnancyCompletedNCT01203527
• A Study to Validate a New Oral Fluid/Saliva Antibody Test for Novel H1N1v InfluenzaCompletedNCT01192958
• Study of the Safety and Immunogenicity of H1N1 VaccineCompletedNCT01177202Phase 1
• Safety of and Immunogenicity to an H1N1 Influenza Vaccine in HIV-infected AdultsCompletedNCT01155037Phase 2
• The Impact of Vitamin on the Clinical Course in Cases Infected by Novel H1N1 Influenza Virus AStatus unknownNCT01127282Phase 4
• Observational Safety and Effectiveness Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived VaccineCompletedNCT01101074
• Rapid Diagnostic Test for InfluenzaCompletedNCT01089816
• Dose Finding Study of Single Dose GHB11L1 in Healthy AdultsCompletedNCT01078701Phase 2
• Respiratory Virus Outpatient Study (FLU 002 Plus)CompletedNCT01056354
• Respiratory Virus Hospitalization Study (FLU 003 Plus)CompletedNCT01056185
• Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 PatientsStatus unknownNCT01055990Phase 2
• Virus Shedding and Environmental Deposition of a Novel Influenza VirusCompletedNCT01046734
• Safety and Efficacy of Oseltamivir in Children Younger Than One Year of AgeWithdrawnNCT01037634Phase 2
• Epidemiology and Clinical Presentation of H1N1 Infection in Children in GenevaCompletedNCT01022931
• Characteristics and Outcomes of Intensive Care Unit Patients Admitted With Novel H1N1 Influenza or Seasonal InfluenzaCompletedNCT01011582
• Antibody Production Following H1N1 Influenza Vaccination After Stem Cell and Heart TransplantationStatus unknownNCT01008683
• Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults With HIVCompletedNCT01002040Phase 4
• Post-Authorization Safety Study of GSK Biologicals' Pandemic Influenza Vaccine (H1N1) in the United KingdomCompletedNCT00996853
• The Influence of Fortified Pomegranate Juice (Punica Granatum) on Seasonal Influenza and Swine Flu PatientsStatus unknownNCT00987012Not applicable
• A Pilot Study for Collection of Anti-Influenza A Immune PlasmaCompletedNCT00984451
• Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Population Aged 3 Years and OlderCompletedNCT00975572Phase 2
• Safety and Immunogenicity of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in ChildrenCompletedNCT00884182Phase 2
• Study of Immune Response in Adults and Elderly Subjects Vaccinated With Inactivated Influenza VaccinesCompletedNCT00776438Phase 2
• Randomized, Double-blind, Placebo-controlled, Phase I Dose-escalation Study of Single Dose GHB01L1 in Healthy VolunteersCompletedNCT00724997Phase 1
• Immunogenicity and Safety of the Inactivated, Split-Virion Influenza Vaccine, Northern Hemisphere 2008-2009 FormulationCompletedNCT00718146Phase 2
• Study of Inactivated, Split-Virion Influenza Vaccine Administered by Intradermal Route Versus Vaxigrip® in AdultsCompletedNCT00703651Phase 2
• Study of Different Formulations of an Intramuscular A/H5N1 Inactivated, Split Virion Influenza Adjuvanted VaccineCompletedNCT00664417Phase 1
• Immunogenicity of the Inactivated Split-Virion Influenza Vaccine in Renal Transplant SubjectsCompletedNCT00606359Phase 2
• Immunogenicity and Safety of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in AdultsCompletedNCT00545701Phase 2
• Safety and Immunogenicity of 2 Formulations of an Intramuscular A/H5N1 Pandemic Influenza Vaccine in ChildrenCompletedNCT00491985Phase 2
• A Study of the Immunogenicity and Safety of the 2007-2008 Influenza VaccineCompletedNCT00491257Phase 2
• Safety and Immunogenicity of H5N1 Adjuvanted, Inactivated, Split-Virion Pandemic Influenza Vaccine in Healthy AdultsCompletedNCT00457509Phase 1
• Safety and Immunogenicity of an Intramuscular Pandemic Influenza Vaccine in Adults and the ElderlyCompletedNCT00415129Phase 2
• Lot-to-Lot Consistency Study of the Investigational, Inactivated, Split-Virion Influenza Vaccine in AdultsCompletedNCT00383539Phase 3
• Study of Inactivated, Split-Virion Influenza Vaccine Compared With the Reference Vaccine Vaxigrip® in the ElderlyCompletedNCT00383526Phase 3
• A Study of the Immunogenicity and Safety of the 2006-2007 Influenza VaccineCompletedNCT00343681Phase 2
• Immunogenicity of Two Dosages of Inactivated, Split-Virion Influenza Vaccine Given by an Alternate Route in the ElderlyCompletedNCT00296829Phase 2
• Immunogenicity Study of the Influenza Vaccine in AdultsCompletedNCT00258934Phase 2

← Orthomyxoviridae Infections overview